Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial.

Stone, Gregg W; Bertrand, Michel E; Moses, Jeffrey W; Ohman, E Magnus; Lincoff, A Michael; Ware, James H; Pocock, Stuart J; McLaurin, Brent T; Cox, David A; Jafar, M Zubair; +12 more... Chandna, Harish; Hartmann, Franz; Leisch, Franz; Strasser, Ruth H; Desaga, Martin; Stuckey, Thomas D; Zelman, Richard B; Lieber, Ira H; Cohen, David J; Mehran, Roxana; White, Harvey D; ACUITY Investigators; (2007) Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial. JAMA, 297 (6). pp. 591-602. ISSN 0098-7484 DOI: https://doi.org/10.1001/jama.297.6.591

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1001/jama.297.6.591

Abstract

Share

Download

Filename: Routine Upstream Initiation vs Deferred Selective Use of Glycoprotein IIbIIIa Inhibitors.pdf

Licence: Copyright the publishers

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar